Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
NEW YORK, April 06, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Rockwell Medical, Inc. (NASDAQ:RMTI) securities between September 9, 2015 and February 29, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/rockwell-medical. There is no cost or obligation to you.
The complaint alleges that the Company failed to disclose that: (1) Rockwell’s main product offering for Triferic has not yet been approved by the FDA; and (2) Rockwell is seeking to obtain transitional add-on payment reimbursement for Triferic with the Centers for Medicare & Medicaid Services instead of bundled reimbursement.
If you suffered a loss in Rockwell Medical you have until May 3, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/rockwell-medical.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
